Feedback / Questions
ibezapolstat (ACX-362E) - Acurx Pharma
https://www.newswire.ca/news-releases/acurx-announces-publication-of-nonclinical-in-vivo-data-differentiating-ibezapolstat-s-gut-microbiome-effects-from-other-anti-cdi-antibiotics-818617065.html
Mar 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next